Early Intervention by Family Physicians to Delay Type 1 Diabetes

Area of Science:

• Immunology
• Endocrinology
• Autoimmune Diseases

Background:

• Type 1 diabetes (T1D) is an autoimmune condition where T cells destroy insulin-producing beta cells.
• Disease progression varies, marked by immune activation and islet autoimmunity.
• Pancreatic islet cell autoantibodies predict T1D progression over weeks to years.

Purpose of the Study:

• To highlight the role of family physicians in identifying individuals at risk for T1D.
• To emphasize the benefits of early screening and intervention for T1D.
• To discuss emerging therapies for delaying, preventing, or reversing T1D.

Main Methods:

• Review of screening options for family physicians.
• Identification of at-risk populations (e.g., relatives, family history of autoimmune disorders).
• Discussion of technological and immunological advances in T1D.

Main Results:

• Screening identifies individuals at risk or in early stages of T1D.
• Early detection facilitates interventions to delay or prevent T1D onset.
• Screening can prevent diabetic ketoacidosis and facilitate insulin therapy transition.

Conclusions:

• Family physicians play a crucial role in T1D management through screening and intervention.
• Early detection and intervention strategies can significantly alter T1D progression.
• Advances in understanding T1D pathogenesis are leading to novel disease-modifying therapies.